Benicar is a brand name for the active ingredient olmesartan medoxil, an angiotensin II receptor blocker (ARB) used to manage high blood pressure. It is supplied as an oral pill in strengths of 10 mg, 20 mg, and 40 mg. In Hong Kong, Benicar is a prescription-only medicine regulated by the Department of Health.
Olmesartan medoxil belongs to the ARB class. After oral absorption, it is converted to olmesartan, which selectively blocks the angiotensin II type 1 (AT₁) receptors. By preventing angiotensin II from binding, the drug:
Onset of blood-pressure reduction typically occurs within 2 hours, with peak effect around 3-6 hours and a duration of action lasting 24 hours, allowing once-daily dosing.
Benicar is approved by health authorities for the following indications:
The medication is intended for adults; pediatric use is not approved.
These effects are usually mild and transient; they often resolve without intervention.
Note: Patients should disclose all prescription medicines, over-the-counter drugs, supplements, and herbal products to their healthcare provider before starting Benicar.
This article provides educational information about Benicar and is not a substitute for professional medical advice. Treatment decisions, including the use of any medication for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Dizziness is a common early side effect, especially when standing quickly. Sit or lie down until it passes, and rise slowly to avoid falls. If dizziness persists or worsens, contact your healthcare provider for possible dose adjustment.
Yes. In fact, a low-sodium diet complements the blood-pressure-lowering effect of Benicar and is often recommended as part of hypertension management.
Benicar tablets are permitted for personal medical use in most countries, but you should carry the prescription label and a copy of the prescribing doctor’s note. Check Hong Kong’s outbound travel guidelines if you plan to bring medication abroad.
Olmesartan is not significantly metabolized by CYP3A4, so grapefruit does not have a clinically relevant interaction. No dietary restriction regarding grapefruit is necessary.
Both are ARBs and share a similar mechanism of action. Olmesartan provides a longer duration of action at once-daily dosing, while individual response may vary. Choice of agent depends on clinical response, tolerance, and physician judgment.
Yes. Combining an ARB with a thiazide diuretic is a common strategy to achieve better blood-pressure control. Your doctor will monitor electrolytes and kidney function during combined therapy.
Swelling of the lips, tongue, throat, or face, especially if it interferes with breathing or swallowing, is an emergency. Seek immediate medical attention or call emergency services.
Olmesartan medoxil is listed in Hong Kong’s Pharmaceutical Registry, and generic versions are permitted when prescribed by a licensed practitioner.
Most patients experience a noticeable reduction within 2 weeks, but the full antihypertensive effect may take up to 4-6 weeks as the body adjusts.
Do not flush tablets down the toilet. Use a community drug-take-back program or follow local pharmacy disposal instructions to prevent accidental ingestion or environmental contamination.
